• Latest Posts

Allergy Therapeutics moves ahead with peanut and grass pollen allergy trials

Shares Drop 40% as Allergy Therapeutics Announces Failed Phase III Trial

Positive House Dust Mite Immunotherapy Results for UK Biotech

Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results

British Rapid Action Allergy Vaccine Gets Approval for Phase II Trial

Suffering from House Dust Mite Allergy? A New Therapy is on its Way


Germany gains Strength in Allergy Immunotherapeutics

UK Biopharma joins Allergy race with good Phase II results for Hayfever